Works matching DE "NORTH Central Cancer Treatment Group (Organization)"


Results: 5
    1

    North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 12, p. 1890, doi. 10.1002/cncr.28654
    By:
    • Leal, Alexis D.;
    • Qin, Rui;
    • Atherton, Pamela J.;
    • Haluska, Paul;
    • Behrens, Robert J.;
    • Tiber, Charles H.;
    • Watanaboonyakhet, Patanit;
    • Weiss, Matthias;
    • Adams, Paul T.;
    • Dockter, Travis J.;
    • Loprinzi, Charles L.
    Publication type:
    Article
    2

    Prognostic Factors Differ by Tumor Stage for Small Cell Lung Cancer.

    Published in:
    Cancer (0008543X), 2009, v. 115, n. 12, p. 2721, doi. 10.1002/cncr.24314
    By:
    • Foster, Nathan P.;
    • Mandrekar, Sumithra J.;
    • Schild, Steven E.;
    • Nelson, Garth D.;
    • Rowland Jr., Kendrith M.;
    • Deming, Richard L.;
    • Kozeisky, Timothy F.;
    • Marks, Randolph S.;
    • Jett, James R.;
    • Adjei, Alex A.
    Publication type:
    Article
    3
    4
    5